Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
This is premium content for Private Briefing subscribers only.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
interested in projections for qcom
Dear Philip:
QCOM is a focus stock in Private Briefing.
Just wanted to LYK.
Respectfully yours;
William Patalon III
Executive Editor
Money Morning & Private Briefing
Great News but always after they take off. What a waste this service is because of the lack of timely information!!
Hi Joseph:
Money Morning is designed as a news/analysis service that provides investors with predictive, leading-edge insights on the trends, looming developments, potential pitfalls and global developments needed to become more successful. We give our readers insights they'll find nowhere else — and give you the "real" story that Wall Street can't or won't. If you're a regular reader, then you know we also provide some investment picks — and not just those that "have already taken off," as you allege. If that's, in fact, your perception, then you can't be a regular reader.
That's a bargain value proposition for a "free" service. I challenge you to show me another free daily service that offers more … or even offers as much — not to mention one written by true market veterans who have actually done what they write about, as opposed to a mainstream news site that's staffed chiefly by journalists who can only "report" what Wall Street tells them.
If you're looking for regular recommendations, I suggest you take a look at one of our dedicated trading services. If cost is an issue, or you want to see what we do, take a look at Private Briefing (26 cents a day) or The Money Map Report. Both have terrific track records and generate excellent feedback from their subscribers.
Respectfully;
William Patalon III
Executive Editor
Money Morning & Private Briefing
The problem with trying to pick individual stock winners is they can often be just like the boats in a harbor. All the boats go down when the tide goes out. If the market as a whole takes the plunge some are predicting, it could have an impact on these IPO's. Then again, maybe not! This market and economy are crazy.
Mr Patalon,
I wish to say that MM is a well written simple, straight forward, no BS letter that is not encumbered by lengthy volumes of unnecessary word pictures…I do not want to read & review a novel of info related to publications…Just make it short, sweet, and to the point. I would very much like to view your other paid for publications if you can provide the links.
Regards;
JJ
Dear John:
Thank you for the kind words. It means a lot.
It goes without saying that any business or company likes to hear from folks who are satisfied with their efforts and products.
In the five-plus years that I've been here, I've seen how we take that feeling to the extreme.
That's not because we feel the need to have our collective egos stroked, or because "it looks good" to other potential customers. The truth is that we understand that our products are a means to an end — in other words, you take the products that we provide and use them to pursue objectives that are deeply personal in nature … financial security, a safe retirement, an education for children or other family loved ones, and even personal wealth.
We care about that. We want you to achieve those goals. We want you to establish security.
And that means that the information, insights and analysis we provide must be spot-on … which most of the time means we're going against the "conventional wisdom" of Wall Street and Washington.
That fact that you and others who have written to us feel that we're doing great work is very gratifying … because it usually means you believe you're on the right path toward your own goals.
And those goals are the ones that really matter — to us, as well as to you.
Sir, thank you again for writing. I will be sure to circulate this internally.
And if you have any questions, insights or want to follow up with me, please feel free to do so at PrivateBriefing@MoneyMorning.com.
Have a warm and safe holiday season. And allow me to wish you, and all those important to you, a safe, fulfilling and prosperous New Year.
Respectfully yours;
William (Bill) Patalon III
Money Morning & Private Briefing
John,
Here's a link that will tell you more about Bill's Private Briefing.
Just copy and paste into your browser: http://moneymorning.com/research-reports/MMP/MMP1011.php?code=WMMPN405&n=MMPROGUEMMRSQUEEZE495ARSHRT
Happy Holidays!
I am learning to use your write ups.
In your 19th's write up of five IPOs SSTK, AMBA, KYTH, ICPT and WDAY have all gone up large % since their issuing date. Is your suggestion to buy they now, or its too late but to wait for other IPOs to come?
Daniel Chang (chang89620)
I only recently became interested in investing with no prior experience. After copious web surfing I plunked down what seemed a very modest amount to access your site because you were the only investing service I found that was predicated on an understanding of the self-inflicted, global problems that we face as a society/economy and species. Not exactly the normal outlook of a stock analyst. I would recommend to fellow readers that they check out Zacks, which offers a very useful, practical complement to this service. You have your fingers on the pulse of the global economies and your perpective uncovers underlying trends and forces that are the real movers behind global and sector trends. Its the best crystal ball I've found thus far. My thanks, and keep up the good work.
I just came across a website that contributes some interesting info concerning your Celsion cancer therapy company. There's a website calle squeezetrigger that uses information from the markets to find out what stocks are getting a high amount of shorts. Being new to investing I didn't know that some institutional investors will intentionally put huge sums into shorting a stock with the purpose of driving the price down. The more they can drive the price down the more they can reap profits. I was checking out this site and it turns out that Celsion is on their list of stocks that have received over half a million shares shorted. So it looks like someone has been purposely trying to drive this company's price down. At this point, however, this site predicts that Celsion is ripe for a price rise. As soon as the shorts go "out of the money" the investors holding this position will start scrambling to buy stock to cover their shorts. This will drive the price up even more, and if one invests in Celsion over the next few days there is an excellent chance that you will hitch a ride on the upswing. I just bought 120 shares–the stock is cheap right now–and will keep my fingers crossed. In some cases there is a short price spike, but in many cases the stock rises and stays at a much higher evaluation.